Concordance of human equilibrative nucleoside transporter‐1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial

BACKGROUND: Expression of human equilibrative nucleoside transporter‐1 (hENT1) is reported to predict survival of gemcitabine (GEM)‐treated patients. However, predictive values of immunohistochemical hENT1 expression may differ according to the antibodies, 10D7G2 and SP120. AIM: We aimed to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamura, Yukiyasu, Boku, Narikazu, Ghaneh, Paula, Greenhalf, William, Yasukawa, Satoru, Narimatsu, Hiroto, Fukutomi, Akira, Konishi, Masaru, Morinaga, Soichiro, Toyama, Hirochika, Maeda, Atsuyuki, Shimizu, Yasuhiro, Nakamori, Shoji, Sata, Naohiro, Yamakita, Keisuke, Takahashi, Amane, Takayama, Wataru, Yamaguchi, Ryuzo, Tomikawa, Moriaki, Yanagisawa, Akio, Neoptolemos, John P., Uesaka, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124504/
https://www.ncbi.nlm.nih.gov/pubmed/34327872
http://dx.doi.org/10.1002/cnr2.1507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124504/
https://www.ncbi.nlm.nih.gov/pubmed/34327872
http://dx.doi.org/10.1002/cnr2.1507

Ejemplares similares